Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Breast Fibrocystic Disease Clinical Trial

Official title: Efficacy and Safety of Nutritional Supplement ONCOXIN in Patients With Breast Fibrocystic Disease

Status Completed

Clinical Trial Summary

The purpose of the study is to evaluate whether Oncoxin, a nutritional supplement, improves the clinical and ultrasonographic results in comparison with placebo during 24 weeks of treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Breast Fibrocystic Disease
• Cystic Fibrosis

• NCT number: NCT00967681
• Study type: Interventional
• Source: Catalysis SL
• Status: Completed
• Phase: Phase 3
• Start date: September 2009
• Completion date: April 2011